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Abstract. Despite recent large-scale investments, malaria remains a major public health concern. Few studies have
examined congenital malaria, defined as the presence of malaria parasitemia within the first 7 days of life, in endemic
areas. This study aimed to determine the prevalence, to describe the clinical presentation, and to examine factors
associatedwith congenital malaria in newborns aged up to 7 days attending TororoGeneral Hospital in Uganda. A total of
261 mother/baby pairs were recruited in this cross-sectional study. Giemsa-stained thick blood smears for malaria
parasites and rapid malaria diagnostic tests were performed on capillary blood samples from all newborns and mothers,
aswell as on placental and cord samples from newborns delivered in the hospital. The prevalence of congenital malaria in
the newborns was 16/261 (6.1%). No single clinical feature was associated with congenital malaria. However, there were
associations between congenital malaria and maternal parasitemia (P < 0.001), gravidity of one (P = 0.03), maternal age
< 19 years (P = 0.01), cord blood parasitemia (P = 0.01), and placental malaria (P = 0.02). In conclusion, congenital malaria
is not rare in Uganda and there are no obvious clinical features associatedwith it in the newborn. Based on these findings,
we recommend strengthening malaria prevention during pregnancy to reduce the occurrence of congenital malaria in
newborns.
INTRODUCTION
In 2017, the WHO reported that there were 219 million cases
ofmalaria, resulting in435,000deaths.1Mostof thecases (80%)
and deaths (90%) were in sub-Saharan Africa, and mainly af-
fectedchildrenyounger than5years.2However, thedevastating
consequences of malaria start before the child is even born and
these children suffer adverse outcomes related to gestational
malaria, placental malaria, and congenital malaria.
During pregnancy, the acquired antimalarial immunity of a
woman residing in a malaria-endemic area decreases.3 Several
studies over the past two decades, especially in Nigeria, have
shown that the prevalence of malaria in neonates appears to be
increasing with values as high as 25%.4,5 The true burden of
congenitalmalaria, however,might be underestimated because
of the nonspecific clinical picture and the absence or the
delayed presentation of symptoms. It is reported that it might
take 3–4 weeks before congenitally infected infants present
symptoms6 and only 34% of parasitemic newborns would
present symptoms within 3 days.7 In Burkina Faso, 11.8% of
newbornswith congenital malaria died and the average amount
of time fromhospital admission todeathwas4.8days,with55%
of deaths occurring in the first 24 hours after admission.8
In Uganda, malaria is still a major public health problem,
accounting for 30–50% of all outpatient consultations and up
to 35% of hospital admissions.9 Recent hospital-based
studies have examined malaria admissions in various parts
of the country, including a 2010 study, that estimated the
prevalence of placentalmalaria to be 74%amongwomenwho
took 0–1 prophylactic doses of sulfadoxine–pyrimethamine
and 60% among women who took 2–3 doses prophylactic
doses of sulfadoxine–pyrimethamine.10 However, few studies
have reported the prevalence and clinical features of con-
genital malaria. Our study aimed to address this gap in the
literature by 1) determining the prevalence of congenital
malaria, 2) describing the clinical features of congenital
malaria, and 3) identifying risk factors for congenital malaria in
Ugandan newborns in the first 7 days of life.
METHODS
Design. This cross-sectional study of congenital malaria
among newborn babies was conducted at Tororo General
Hospital in Uganda from February to April 2014.
Setting. Tororo is a rural district in southeastern Uganda
approximately 230 km east of the capital city, Kampala. The
district experienceshyperintensemalaria transmissionwith an
estimated entomological inoculation rate of 562 infective
bites per person year (approximately 1.5 infectious bites
every day).11 The incidence of malaria in this area has a bi-
modal distribution that follows the rainy seasons of March to
May and September toNovember. TororoGeneral Hospital is a
public 200-bed hospital serving a catchment population of
approximately 500,000 people. Between 230 and 330mothers
deliver at the Tororo General Hospital every month.
Participants. Participants were newborn babies, aged up
to 7 days born at or who attended the Tororo General Hospital
for other services, for example, for immunization or neonatal
illness during the study period, and their mothers. Macerated
and fresh still births were excluded.
Procedures. Recruitment. Written informed consent was
obtained from mother. Participants were then recruited by
convenience to achieve the sample size. Mother/baby pairs
delivering in the hospital were recruited within the first hour
followingbirth. In addition, newbornsbabies agedup to 7days
who were admitted to the pediatric ward for any condition, or
who were delivered late at night or from elsewhere but atten-
ded the immunization unit in the postnatal ward were also
selected for enrollment.
Data collection. Clinical data. A medical officer was trained
as a research assistant to assist in data collection. A standard
questionnairewas administered to all study subjects by one of
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the investigators (M. H.) or the research assistant. The ques-
tionnaire including sociodemographic data, gravidity, gesta-
tional age (estimatedbyNaegle’s ruleusing theself-reported last
menstrual date recorded on the antenatal card at the first pre-
natal visit), use of treated mosquito bed nets, and antimalarial
medicines for both treatment and prevention during the preg-
nancy. The interview was performed face to face with the
mothers ineitherEnglishor inoneof the local language inTororo.
All newbornparticipants hada full physical examination. The
newborn weight (in kilograms) was obtained using an elec-
tronic baby scale (SECA, Model, Nagano City, Japan); length
(in centimeters) wasmeasured in the dorsal decubitus position
using Stadiometer, whereas the head circumference (in cen-
timeters) was determined using a flexible measuring tape.
Axillary temperature was determined using a digital ther-
mometer and pyrexia was defined as temperature ³ 37.5C.
The presence of congenital abnormalities, dysmorphic fea-
tures, as well as pallor of the mucus membranes, jaundice,
enlargement of the liver andspleen, andneonatal reflexeswere
documented for each participant.
Laboratory testing. Malaria was diagnosed by microscopic
examination of Giemsa-stained blood smears (BSs).
Blood from finger prick samples (mothers) and foot prick
samples (newborns) was used to prepare the thick smears.
The smears were air-dried and stained for 30 minutes using
2% Giemsa. Two experienced microscopists read the thick
smears at ×100 magnification using immersion oil. Positive
BSs were defined as parasite density ³ 1 parasite/μL. Smears
were considered negative if no malaria parasites were found
after review of 100 high-power fields. Parasite density was
also determined. The twomicroscopists were blinded to each
other’s readings, and discrepant readings were settled by a
third microscopist.
For babies delivered at Tororo General Hospital, within an
hour of delivery, 1 mL of placental bloodwas also collected in
a sterile ethylenediamine tetraacetic acid (EDTA) tube using
the incision method.12 This method consisted of making a
shallow incision into the maternal side of the placenta with
scissors and collecting blood that pooled in the intervillous
space. A separate collection was made from the cord. To do
so, the cord was cleaned with a 70% alcohol swab to prevent
contamination with maternal blood and 1 mL of cord blood
was taken from the umbilical cord about 15 cm from the point
of attachment to the placenta.
Thick BSs were prepared within 24 hours from blood sam-
ples obtained from the cord and placenta and they were ex-
amined using the same procedure as peripheral BSs.
In addition,malaria rapid diagnostic tests (RDT) (MalariaAgP.f
HRP-II Rapid Test, Somerset, NJ) were also performed on all
blood samples. A positive malaria test was defined as any pos-
itive result on either BS or RDT. In addition, hemoglobin levels
were measured using a Hemocue Photometer version 3.0.1
(Model 3000-0031-6801, EKF Diagnostic, Barleben, Germany).
Anemia was diagnosed if the hemoglobin level was < 15 g/dL.13
HIV testing is routine for all women delivering at Tororo
General Hospital with uptakes of up to 100% antenatal HIV
testing.14 For women without HIV test results at enrollment,
an HIV test was performed using a rapid test (Determine
HIV-1/2; Alere Medical co., Ltd., Chiba, Japan) following
Ugandan guidelines as in the National HIV testing algorithm.
Pre- and posttest counseling by a qualified counselor was
performed.
Ethics, consent, and permissions. Ethical approval for
the study was provided by Makerere University School of
Medicine Research and Ethics Committee. Written informed
consent for participation was obtained from all mothers.
Participantswho tested positive formalariawere treatedwith
a full course of quinine (newborns) or artemether–lumefantrine
(mothers).
Data analysis.Data entry was performed using Epidata 3.1
(“The EpiData Association,” Odense, Denmark) and exported
to SPSS (version 19; IBMSPSS 17, 18 and 19, Chicago, IL) for
analysis. Theprevalence of congenitalmalariawascalculated.
Normally distributed continuous data were summarized by
medianswith ranges. Fisher’s exact test was used to compare
categorical data to establish whether an association existed
between congenital malaria and explanatory variables. A
P-value < 0.05 was considered statistically significant.
RESULTS
From February 14, 2014 to April 4, 2014, 264 mother/baby
pairs were screened. Three mothers denied consent. Thus, a
final sample of 261 mother/baby pairs were recruited (see
Figure 1).
The prevalence of congenital malaria. The prevalence of
congenital malaria was 16/261 (6.1%). All cases were positive
on both microscopy and RDT.
Clinical presentation of the newborns with malaria.
Babies with congenital malaria were similar to those without
congenital malaria with regard to gestational age, Apgar
scores, birth weight, fetal length, and body temperature. The
proportion with jaundice, mucosal pallor, hepatomegaly or
splenomegaly, and the hemoglobin levels were also similar
(Table 1). The median parasite density in newborns with con-
genital malaria was 460 parasites/μL (range: 80–1,550 para-
sites/μL). Overall, no specific clinical feature was associated
with congenital malaria. Instead, most newborns with con-
genital malaria had a normal clinical examination. Only one
newborn (6.2%) with congenital malaria had a temperature
>37.5Candanother (6.2%)hadahemoglobin level <15g/dL.
Newborns with congenital malaria had a median birth weight
of 3.2 kg (range: 2.8–3.5 kg), median gestational age of
39weeks (range: 38–40weeks), amedian fetal length of 50 cm
(range: 49–50 cm), a median temperature of 36.4C (range:
36–36.8C), and a median hemoglobin level of 18.3 g/dL
(range: 16.7–19.9C).
Sociodemographic and maternal factors associated
with congenital malaria. The household factors, maternal
factors, and other factors (placental malaria and cord blood
parasitemia) were analyzed using bivariate analysis. Risk
factors associated with congenital malaria included the first
pregnancy, teenage pregnancy (maternal age < 19 years),
maternal malaria parasitemia at the time of delivery, placental
malaria, and cord blood parasitemia. Factors found to be
protective against congenital malaria included mothers re-
siding in a brick house, mothers residing in a house with iron
sheet roof, and mothers who had malaria and were treated
with quinine during pregnancy (Table 2).
General results for RDT and thick smears. The preva-
lence of cord blood parasitemia on RDT and thick smear was
3/54 (5.6%) and 1/54 (1.8%), respectively. The prevalence of
placental malaria on RDT and thick smear was 9/54 (16.7%)
and 9/54 (16.7%), respectively. The prevalence of maternal
CONGENITAL MALARIA IN NEWBORNS 1159
malaria on RDT and thick smear was 27/261 (10.3%) and 23/
261 (8.8%), respectively (Table 3).
DISCUSSION
This study aimed to determine the prevalence of congenital
malaria, to describe the clinical features of congenital malaria,
and to identify risk factors for congenital malaria in Ugandan
newborns in the first seven 7 days of life.
The prevalence of congenital malaria in Tororo General
Hospital was 6.1% (16/261; 95% CI: 3.2–9%). This preva-
lence data are similar to reports in Tanzania, Burkina Faso,
and Nigeria,15–17 but higher than those in Burundi and the
Calabar area of Nigeria.18,19 Two studies that used poly-
merase chain reaction (PCR) to detect malaria parasitemia
found a higher prevalence of congenital malaria but this is
most likely because of the more sensitive detection method
used.20,21 Thus, these observed differences in congenital
FIGURE 1. Study Profile. Subject recruitment flowchart is depicted using a consecutive sampling technique. Fifty-four newborns and their
mothers were recruited from the labor suite, followed by recruitment of 208 newborns and their mothers in the immunization unit, and then by
recruitment of two newborns and their mothers in the pediatric ward. Three mothers withdrew consent to make a final sample size of 261 mothers
and their newborns. Blood smears andRDTwere performed on all 261 newborns. Sixteenwere positive, making a prevalence of congenital malaria
to be 6.1%. RDT = rapid diagnostic test for malaria.
TABLE 1
Clinical presentation of the newborns
Variables Outcome
Congenital malaria
OR 95% CI P-value
Positive Negative
N (%) N (%)
Birth weight (kg) < 2.5 0 (0.0) 11 (4.5) NA NA 0.49
³ 2.5 16 (100.0) 234 (95.5)
Gestational age (week) < 37 0 (0.0) 6 (2.4) NA NA 0.68
³ 37 16 (100.0) 239 (97.6)
Apgar score 4–6 0 (0.0) 3 (1.2) NA NA 0.83
7–10 16 (100.0) 242 (98.8)
Fetal length (cm) < 49.5 0 (0.0) 16 (6.5) NA NA 0.32
³ 49.5 16 (100.0) 229 (93.5)
Temperature (C) < 37.5 15 (93.8) 242 (93.8) 5.38 0.53–54.86 0.23
³ 37.5 1 ( 6.2) 3 (1.2)
Jaundice Yes 0 (0.0) 4 (1.6) NA NA 0.78
No 16 (100.0) 241 (98.4)
Pallor Yes 0 (0.0) 2 (0.8) NA NA 0.88
No 16 (100.0) 243 (99.2)
Hepatomegaly Yes 0 (0.0) 2 (0.8) NA NA 0.72
No 16 (100.0) 243 (99.2)
Splenomegaly Yes 0 (0.0) 0 (0.0) NA NA NA
No 16 (100.0) 245 (100.0)
Hemoglobin level (g/dL) < 15 1 (6.2) 4 (1.6) 4.02 0.42–38.21 0.27
³ 15 15 (93.8) 241 (98.4)
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malaria prevalence could be related to varying utilization
rates of malaria preventive measures during pregnancy,
differences in malaria transmission intensity, or the labo-
ratory operational techniques used in the various studies. In
Tororo district, the large-scale distribution of insecticide-
treated mosquito nets by the Ministry of Health of Uganda
to all households just before the survey could explain the
lower than expected prevalence of congenital malaria
compared with the prevalence reported in other areas of
similar transmission in Africa.
We did not find any clinical characteristics in the newborns
that were significantly associated with congenital malaria. In
our study, birth weight and anemia were not affected by
congenital malaria. In fact, most newborns with congenital
malaria were clinically normal. This presents a diagnostic
challenge because cliniciansmay not suspectmalaria in these
newborns, who are otherwise healthy and have a normal ex-
amination. Our observation is similar to that in Burkina Faso,8
Nigeria,22 andGhana20 wheremost newborns with congenital
malaria were asymptomatic. Similarly, in Tanzania,15 newborn
birth weight was not associated with congenital malaria,
and, in Lagos, anemia was not associated with congenital
malaria.23 On the contrary, Nagaraj et al. in India24 and
Mwaniki et al. in Kenya25 found anemia to be one of
the features of congenital malaria at birth. In addition,
Okechukwu et al. in Abuja, Nigeria,26 found that hepatomeg-
aly, fever, and jaundice were associated with congenital
malaria. Low birth weight, anemia, and prematurity were the
most common features associated with congenital malaria in
Maumere, Indonesia.27 The presence of malaria parasites in
asymptomatic newborns is documented to increase the risk of
anemia in infancy.28 It has been hypothesized that the effec-
tiveness of the placenta as a barrier, the presence of maternal
antibodies, and the protective effect of fetal hemoglobin may
all make congenital malaria rare in this population.29 However,
reasons for decreased malaria in this young population are
generally unknown.
It is also reported that it could take 3–4 weeks before con-
genitally infected infants present with symptoms6 and only
34% of parasitemic newborns present with symptoms within
3 days.7 The fact that we did not find an association between
TABLE 2
Household, maternal, and other characteristics associated with congenital malaria
Variables Outcome
Congenital malaria
OR 95% CI P-value
Positive Negative
N (%) N (%)
Household factors Wall type Brick 1 (6.2) 76 (29.5) 0.15 0.02–1.14 0.03
Mud 15 (93.8) 169 (69.0)
Roof type Iron sheet 7 (43.8) 179 (73.3) 0.29 0.10–0.80 0.02
Grass 9 (56.2) 66 (26.9)
Use spray Yes 1 (6.2) 19 (7.8) 0.79 0.10–6.33 0.65
No 15 (93.8) 226 (92.2)
Use of Net Non-ITN 0 (0.0) 4 (1.6) NA NA 0.76
ITN 16 (100.0) 241 (98.4)
Family size < 5 person 9 (56.2) 87 (35.5) 1.07 1.03–1.10 0.08
³ 5 person 7 (43.8) 158 (64.5)
Maternal factors Malaria treated during pregnancy Quinine 4 (100.0) 24 (32.0) 0.86 0.74–0.10 0.01
Other* 0 (0.0) 51 (68.0)
Chemoprevention during
pregnancy
IPT-SP 15 (93.8) 239 (97.6) NA NA 0.11
TS 1 (6.2) 0 (0.0)
Both 0 (0.0) 4 (1.6)
None 0 (0.0) 2 (0.80)
Gravidity G1 9 (56.2) 74 (30.2) 2.97 1.07–8.28 0.03
³ G2 7 (43) 171 (69.8)
Maternal age < 19 years 8 (50.0) 46 (18.8) 4.33 1.54–12.13 0.01
³ 19 8 (50.0) 199 (81.2)
Level of education Primary 10 (62.5) 152 (62.0) 1.02 0.36–2.90 0.60
Post Primary 6 (37.5) 93 (38.0)
Fever during pregnancy 1st and 2nd trimester 6 (60.0) 71 (81.6) 0.34 0.09–1.34 0.12
3rd trimester 4 (40.0) 16 (18.4)
HIV status during pregnancy Positive 1 (6.2) 6 (2.4) 2.66 0.30–23.50 0.36
Negative 15 (93.8) 239 (97.6)
Maternal malaria at delivery Yes 8 (50.0) 19 (7.8) 11.90 4.02–35.24 0.00
No 8 (50.0) 226 (92.2)
Other factors Placental malaria Yes 3 (75.0) 8 (15.4) 16.50 1.52–179.22 0.02
No 1 (25.0) 44 (84.6)
Cord blood parasitemia Yes 2 (50.0) 1 (2.0) 49.00 3.02–794.52 0.01
No 2 (50.0) 49 (98.0)
ITN = insecticide treated net; SP = sulfadoxine/ pyrimethamine; TS = trimethoprim/sulfamethoxazole. A P-value < 0.05 was considered statistically significant. The bold values in table two show
association between congenital malaria and those concerned explanatory variables on binary analysis.
* Other antimalarial drugs included Coartem and Fansidar.
TABLE 3
General results for RDT and thick smears
Test
RDT Thick smear
TotalPositive Negative Positive Negative
Cord 3 (5.6) 51 (94.4) 1 (1.9) 53 (98.1) 54
Placenta 9 (16.7) 45 (83.3) 9 (16.7) 45 (83.3) 54
Newborns 16 (6.1) 245 (93.9) 16 (6.1) 245 (93.9) 261
Maternal 27 (10.3) 234 (89.7) 23 (8.8) 238 (91.2) 261
RDT = rapid diagnostic test.
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clinical symptoms and congenital malaria may be because of
our selection criteria. In our study, all newbornswere 1–7 days
of age and most of them were recruited from the labor suite
and immunization clinics of the postnatal ward, increasing the
likelihood that our newborns were healthy. On the other hand,
the study in Abuja26 only included newborns with suspected
neonatal sepsis and the study in Indonesia and Kenya25 only
included newborns hospitalized for various health conditions,
biasing their samples toward sicker newborns. Furthermore,
in highly endemic andstable transmission regions, suchasour
study site, signs and symptoms of active malaria infection in
newborns are infrequent.30,31
In this study, maternal malaria parasitemia at delivery, gra-
vidity of one, maternal age less than 19 years, cord blood
parasitemia, and placental malaria were associated with
congenital malaria. However, factors found to be protective
against congenital malaria included mothers residing in brick
houses or houses with iron sheet roofs and mothers who had
malaria treated with quinine during pregnancy. In Benin, there
was no association between maternal sociodemographic
factors and congenital malaria.32 However, there was an as-
sociation between maternal malaria parasitemia and con-
genitalmalaria in studies fromBenin andCalabar, Nigeria.19,33
Other previous studies have also reported multiple factors
associatedwith congenital malaria, such us placental malaria,
cord blood parasitemia, gravidity of one, and maternal age
less than 19 years, as was the case in this study.15,21,34–36
We show that mothers who had malaria during pregnancy
and who were treated with quinine were less likely to deliver
newborns with congenital malaria. Our study also shows that
mothers whowere sleeping in brick homes and in houseswith
iron sheet roofs (possibly indicative of a higher socioeconomic
status) were less likely to deliver newborns with congenital
malaria. An earlier study in Tanzania had found a higher
number of mosquitoes in houses with mud walls or grass/
thatch roofing than in cement-plastered walls and metal
roofing, and these houses also had an increased risk of indoor
mosquito bites, resulting in a higher risk of malaria trans-
mission.37 The increased risk of mosquito bites in the mud
walls and grass/thatch roofing houses could increase the risk
of malaria in pregnant mothers, thereby increasing the risk of
congenital malaria in their newborns. This study had some
limitations that could have impacted on our findings. First, we
did not use PCR for diagnosis of malaria, which is a more
sensitive diagnostic approach. Second, we did not follow up
the newborns to assess for their long-term outcome and also
improve our understanding of the dynamics of malaria trans-
mission and risk in this population in the first 1 week of life.
Third, we may have selected healthier newborns, given our
recruitment sites at the health facility and, in doing so, po-
tentially underestimated the true burden of congenital malaria
in the community.
Despite these limitations, we believe the study findings
have important public health implications. These findings
suggest that congenital malaria is not rare in Uganda but that
there are no obvious clinical signs or symptoms associated
with it, thus presenting a diagnostic dilemma for health
workers. There was an association between congenital
malaria and maternal malaria parasitemia at delivery, ma-
ternal age less than 19 years, gravidity of one, placental
malaria, and cord blood parasitemia. Based on the findings,
we recommended the strengthening of malaria prevention
and treatment during pregnancy to improve pregnancy out-
comes overall and to reduce the occurrence of congenital
malaria in newborns.
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